Gly-7-MAD-MDCPT (TFA)
Gly-7-MAD-MDCPT (Compound 4b) TFA is an anticancer agent. Gly-7-MAD-MDCPT TFA is a Camptothecin compound, which shows cytotoxicity to various cancer cells with IC50 values of 10-1000 nM[1].
Product Specifications
UNSPSC
12352203
Target
ADC Payload; Topoisomerase
Related Pathways
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage
Field of Research
Cancer
Purity
95.15
Smiles
NCC(NCC1=C2C(C(N3C2)=CC([C@](O)(C(OC4)=O)CC)=C4C3=O)=NC5=CC(OCO6)=C6C=C51)=O.O=C(O)C(F)(F)F
Molecular Formula
C26H23F3N4O9
Molecular Weight
592.48
References & Citations
[1]Jeffrey Scott, et al. Preparation of camptothecin peptide conjugates as antitumor agents. WO2019195665. 2019 10-10.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
ADC Related
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
WGC60601-01 50 mg
2- (1H-1,2,4-Triazol-1-yl) pyridine-4-carboximidamide hydrochloride
Sign In for Pricing
View Details WGC60601-02 100 mg
2- (1H-1,2,4-Triazol-1-yl) pyridine-4-carboximidamide hydrochloride
Sign In for Pricing
View Details WGC60601-03 250 mg
2- (1H-1,2,4-Triazol-1-yl) pyridine-4-carboximidamide hydrochloride
Sign In for Pricing
View Details WGC60601-04 500 mg
2- (1H-1,2,4-Triazol-1-yl) pyridine-4-carboximidamide hydrochloride
Sign In for Pricing
View Details